Page last updated: 2024-10-21

14,15-epoxy-5,8,11-eicosatrienoic acid and Hypertriglyceridemia

14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Hypertriglyceridemia in 1 studies

14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation

Hypertriglyceridemia: A condition of elevated levels of TRIGLYCERIDES in the blood.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chadderdon, SM1
Belcik, JT1
Smith, E1
Pranger, L1
Kievit, P1
Grove, KL1
Lindner, JR1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Physical Activity and Obesity: The Role of Nitric Oxide and Eicosanoids in Regulating Capillary Perfusion and Vascular Insulin Resistance[NCT02060240]30 participants (Actual)Interventional2014-02-28Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Hypertriglyceridemia

ArticleYear
Activity restriction, impaired capillary function, and the development of insulin resistance in lean primates.
    American journal of physiology. Endocrinology and metabolism, 2012, Sep-01, Volume: 303, Issue:5

    Topics: 8,11,14-Eicosatrienoic Acid; Animals; Brachial Artery; Capillaries; Contrast Media; Glucose Toleranc

2012